Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Dietary composition

From: Restoration of dietary-fat induced blood–brain barrier dysfunction by anti-inflammatory lipid-modulating agents

  SFA diet LF diet
Calculated nutritional parameters (%)   
Protein 13.6 13.6
Total Fat 20.3 4
Crude Fibre 4.7 4.7
Acid Detergent Fibre 4.7 4.7
Total Carbohydrate 50 64.9
Digestible Energy 18.8 MJ/kg 15.1 MJ/kg
% Digestible Energy from Lipids 40 n/a
% Digestible Energy from Protein 15 n/a
Calculated fat composition (%)   
Myristic Acid 14:0 0.05 Trace
Pentadecanoic Acid 15:0 0.01 n/a
Palmitic Acid 16:0 5.16 0.2
Megaric Acid 17:0 0.05 n/a
Stearic Acid 18:0 7.31 0.1
Arachidic Acid 20:0 0.24 n/a
Behenic Acid 22:0 0.04 n/a
Tetracosanoic Acid 24:0 0.03 n/a
Palmitoleic Acid 16:1 0.05 Trace
Heptadecenoic Acid 17:1 0.01 n/a
Oleic Acid 18:1 n9 6.62 2.4
Gadoleic Acid 20:1 0.01 n/a
Lenoleic Acid 18:2 n6 0.67 0.8
a Linolenic Acid 18:3 n3 0.05 0.4
g Linolenic Acid 18:3 n6 Not detected n/a
Arachadonic Acid 20:4 n6 Not detected Trace
EPA 20:5 n3 Not detected Trace
DHA 22:6 n3 Not detected Trace
  1. The table shows the total fatty acid composition of SFA and LF. Vitamin and mineral content were balanced in all diets. The agents were incorporated into either LF or SFA chow at a concentration of 20 mg/kg (w/w) atorvastatin, 23.4 mg/kg (w/w) pravastatin and 333.3 mg/kg (w/w) ibuprofen.